Sep.1-2,2010,Shanghai,Clinical Trials International Summit 2010 will be held by JFPS China, supported by Contract Research Organization Union (CROU) and Chinese Pharmacological Society. The event will attract senior clinical trial practitioners from world famous pharmaceutical companies, biotechnology companies, medical device companies,contract research organizations (CRO), laboratories and clinical research centers.

Clinical Trial is always regarded as the most time consuming phase in new drug’s R&D. In order to shorten the R&D cycle and accelerate the launch of new products, more and more pharmaceutical companies choose to outsource their clinical trials to more professional clinical research organizations. Drug development outsourcing encouraged the booming of a huge new market.

This summit will focus on:
1.The Development Trends of China Biomedical R&D Model
2.Function Mode of IRB in China and Its Governance Mechanism
3.Latest Achievements of Global Translational Medicine Research
4.Clinical Research Development Status in India and Its Reference Value for China
5.China's First Large Scale Vaccine Clinical Trial in Hepatitis E
6.How to Implement Global Trials in China and Make the Clinical Trials Data to be Accepted in Global

The speakers are Trial Director & Clinical Director from Pfizer, Wockhardt, Bristol-Myers Squibb,Merck,Ranbaxy Laboratories,aTyr Pharma,Intrexon Corporation,GlaxoSmithKline,Novo Nordisk,Bayer HealthCare,Biogen Idec,Innovax...

Read More....